ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Gossamer Bio Inc

Gossamer Bio Inc (GOSS)

1.02
0.05
(5.15%)
終了 1月4日 6:00AM
0.961
-0.059
( -5.78% )
プレマーケット: 6:11PM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
0.961
買値
0.961
売値
1.05
出来高
5,269
0.00 日の範囲 0.00
0.4993 52 週間の範囲 1.60
時価総額
前日終値
1.02
始値
-
最終取引時間
18:11:31
財務取引量
-
VWAP
-
平均取引量 (3 か月)
1,337,166
発行済株式数
226,604,137
配当利回り
-
PER
-1.29
1 株当たり利益 (EPS)
-0.79
歳入
-
純利益
-179.82M

Gossamer Bio Inc について

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth,... Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Gossamer Bio Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker GOSS. The last closing price for Gossamer Bio was US$1.02. Over the last year, Gossamer Bio shares have traded in a share price range of US$ 0.4993 to US$ 1.60.

Gossamer Bio currently has 226,604,137 shares in issue. The market capitalisation of Gossamer Bio is US$231.14 million. Gossamer Bio has a price to earnings ratio (PE ratio) of -1.29.

GOSS 最新ニュース

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension...

Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

- $327 Million in Cash, Cash Equivalents & Marketable Securities, as of September 30, 2024 - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the...

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension...

Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024

- Additional Phase 2 TORREY Open-Label Extension Data to be Presented in Vienna - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.130115.6577205440.83091.030.80811181570.9546853CS
40.20126.44736842110.761.10.7119073210.89297128CS
120.0111.157894736840.951.10.661713371660.83503618CS
26-0.119-11.01851851851.081.370.661712046740.9217593CS
520.0444.798255179930.9171.60.499314757380.908094CS
156-10.149-91.350135013511.1115.1950.452520421492.91200036CS
260-14.229-93.673469387815.1916.790.452514527834.23711213CS

GOSS - Frequently Asked Questions (FAQ)

What is the current Gossamer Bio share price?
The current share price of Gossamer Bio is US$ 0.961
How many Gossamer Bio shares are in issue?
Gossamer Bio has 226,604,137 shares in issue
What is the market cap of Gossamer Bio?
The market capitalisation of Gossamer Bio is USD 231.14M
What is the 1 year trading range for Gossamer Bio share price?
Gossamer Bio has traded in the range of US$ 0.4993 to US$ 1.60 during the past year
What is the PE ratio of Gossamer Bio?
The price to earnings ratio of Gossamer Bio is -1.29
What is the reporting currency for Gossamer Bio?
Gossamer Bio reports financial results in USD
What is the latest annual profit for Gossamer Bio?
The latest annual profit of Gossamer Bio is USD -179.82M
What is the registered address of Gossamer Bio?
The registered address for Gossamer Bio is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Gossamer Bio website address?
The website address for Gossamer Bio is www.gossamerbio.com
Which industry sector does Gossamer Bio operate in?
Gossamer Bio operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
KITTNauticus Robotics Inc
US$ 7.40
(94.74%)
7.05M
MEGLMagic Empire Global Limited
US$ 1.07
(90.36%)
7.94M
EKSOEkso Bionics Holdings Inc
US$ 1.37
(87.67%)
9.99M
FGLFounder Group Limited
US$ 2.42
(58.17%)
461.24k
EMSmart Share Global Limited
US$ 1.05
(46.81%)
751.32k
ACONAclarion Inc
US$ 0.2066
(-30.76%)
1.23M
BCTXBriaCell Therapeutics Corporation
US$ 0.514
(-19.78%)
43.94k
MFImF International Ltd
US$ 1.03
(-19.53%)
210.99k
CPHCCanterbury Park Holding Corporation New
US$ 17.00
(-19.05%)
201
AFRIForafric Global PLC
US$ 8.30
(-18.79%)
3
CNSPCNS Pharmaceuticals Inc
US$ 0.1497
(21.71%)
36.98M
EKSOEkso Bionics Holdings Inc
US$ 1.37
(87.67%)
9.99M
MEGLMagic Empire Global Limited
US$ 1.07
(90.36%)
7.94M
KITTNauticus Robotics Inc
US$ 7.40
(94.74%)
7.05M
RRRichtech Robotics Inc
US$ 5.77
(41.08%)
5.36M

GOSS Discussion

投稿を表示

最近閲覧した銘柄